The dysfunction of the DNA mismatch repair system results in microsatellite instability (MSI). MSI plays a central role in the development of multiple human cancers. In colon cancer, despite being associated with resistance to 5-fluorouracil treatment, MSI is a favourable prognostic marker. In gastric and endometrial cancers, its prognostic value is not so well established. Nevertheless, recognising the MSI tumours may be important for predicting the therapeutic effect of immune checkpoint inhibitors. Several gene expression signatures were trained on microarray data sets to understand the regulatory mechanisms underlying microsatellite instability in colorectal cancer. A wealth of expression data already exists in the form of microarray data sets. However, the RNA-seq has become a routine for transcriptome analysis. A new MSI gene expression signature presented here is the first to be valid across two different platforms, microarrays and RNA-seq. In the case of colon cancer, its estimated performance was (i) AUC = 0.94, 95% CI = (0.90 - 0.97) on RNA-seq and (ii) AUC = 0.95, 95% CI = (0.92 - 0.97) on microarray. The 25-gene expression signature was also validated in two independent microarray colon cancer data sets. Despite being derived from colorectal cancer, the signature maintained good performance on RNA-seq and microarray gastric cancer data sets (AUC = 0.90, 95% CI = (0.85 - 0.94) and AUC = 0.83, 95% CI = (0.69 - 0.97), respectively). Furthermore, this classifier retained high concordance even when classifying RNA-seq endometrial cancers (AUC = 0.71, 95% CI = (0.62 - 0.81). These results indicate that the new signature was able to remove the platform-specific differences while preserving the underlying biological differences between MSI/MSS phenotypes in colon cancer samples.

Faculty of Informatics Masarykova Univerzita Botanická 68a Brno 602 00 Czech Republic

Faculty of Science Research Centre for Toxic Compounds in the Environment Masarykova Univerzita Kamenice 5 Brno 625 00 Czech Republic

Zobrazit více v PubMed

Boland C. R., Thibodeau S. N., Hamilton S. R., et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Research. 1998;58(22):5248–5257. PubMed

Umar A., Boland C. R., Terdiman J. P., et al. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute. 2004;96:261–268. doi: 10.1093/jnci/dji158. PubMed DOI PMC

Nowak J. A., Yurgelun M. B., Bruce J. L., et al. Detection of mismatch repair deficiency and microsatellite instability in colorectal adenocarcinoma by targeted next-generation sequencing. The Journal of Molecular Diagnostics. 2017;19(1):84–91. doi: 10.1016/j.jmoldx.2016.07.010. PubMed DOI PMC

Rustgi A. K. The genetics of hereditary colon cancer. Genes & Development. 2007;21(20):2525–2538. doi: 10.1101/gad.1593107. PubMed DOI

Herman J. G., Umar A., Polyak K., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proceedings of the National Acadamy of Sciences of the United States of America. 1998;95(12):6870–6875. doi: 10.1073/pnas.95.12.6870. PubMed DOI PMC

Kane M. F., Loda M., Gaida G. M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Research. 1997;57(5):808–811. PubMed

Peltomäki P. Deficient DNA mismatch repair: A common etiologic factor for colon cancer. Human Molecular Genetics. 2001;10(7):735–740. doi: 10.1093/hmg/10.7.735. PubMed DOI

Koopman M., Kortman G. A. M., Mekenkamp L., et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. British Journal of Cancer. 2009;100(2):266–273. doi: 10.1038/sj.bjc.6604867. PubMed DOI PMC

Sankila R., Aaltonen L. A., Jarvinen H. J., Mecklin J.-P. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996;110(3):682–687. doi: 10.1053/gast.1996.v110.pm8608876. PubMed DOI

Samowitz W. S., Curtin K., Ma K. N., et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiology, Biomarkers & Prevention. 2001;10:917–923. PubMed

Giacomini C. P., Leung S. Y., Chen X., et al. A gene expression signature of genetic instability in colon cancer. American Association for Cancer Research. 2005;65(20):9200–9205. doi: 10.1158/0008-5472.CAN-04-4163. PubMed DOI

Kruhøffer M., Jensen J. L., Laiho P., et al. Gene expression signatures for colorectal cancer microsatellite status and HNPCC. British Journal of Cancer. 2005;92(12):2240–2248. doi: 10.1038/sj.bjc.6602621. PubMed DOI PMC

Lanza G., Ferracin M., Gafà R., et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Molecular Cancer. 2007;6, article no. 54 doi: 10.1186/1476-4598-6-54. PubMed DOI PMC

Tian S., Roepman P., Popovici V., et al. A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency. The Journal of Pathology. 2012;228(4):586–595. doi: 10.1002/path.4092. PubMed DOI PMC

Zhang T.-M., Huang T., Wang R.-F. Cross talk of chromosome instability, cpg island methylator phenotype and mismatch repair in colorectal cancer. Oncology Letters. 2018;16(2):1736–1746. PubMed PMC

Ribic C. M., Sargent D. J., Moore M. J., et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. The New England Journal of Medicine. 2003;349(3):1166–1170. doi: 10.1056/NEJMoa022289. PubMed DOI PMC

Hong S. P., Min B. S., Kim T. I., et al. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. European Journal of Cancer. 2012;48(8):1235–1243. doi: 10.1016/j.ejca.2011.10.005. PubMed DOI

The Cancer Genome Atlas. http://cancergenome.nih.gov.

GeneExpression Omnibus. https://www.ncbi.nlm.nih.gov/geo.

DeLong E. R., DeLong D. M., Clarke-Pearson D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. doi: 10.2307/2531595. PubMed DOI

Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society B: Methodological. 1995;57(1):289–300.

Watanabe T., Kobunai T., Toda E., et al. Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. Cancer Research. 2006;66(20):9804–9808. doi: 10.1158/0008-5472.CAN-06-1163. PubMed DOI

Koinuma K., Yamashita Y., Liu W., et al. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene. 2006;25(1):139–146. doi: 10.1038/sj.onc.1209009. PubMed DOI

Sansom O. J., Meniel V. S., Muncan V., et al. Myc deletion rescues Apc deficiency in the small intestine. Nature. 2007;446(7136):676–679. doi: 10.1038/nature05674. PubMed DOI

Robinson M. D., Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biology. 2010;11(3, article R25) doi: 10.1186/gb-2010-11-3-r25. PubMed DOI PMC

Robinson M. D., McCarthy D. J., Smyth G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi: 10.1093/bioinformatics/btp616. PubMed DOI PMC

Brettschneider J., Collin F., Bolstad B. M., Speed T. P. Quality assessment for short oligonucleotide microarray data. Technometrics. A Journal of Statistics for the Physical, Chemical and Engineering Sciences. 2008;50(3):241–264. doi: 10.1198/004017008000000334. DOI

Irizarry R. A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–264. doi: 10.1093/biostatistics/4.2.249. PubMed DOI

Robin X., Turck N., Hainard A., et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12, article 77 doi: 10.1186/1471-2105-12-77. PubMed DOI PMC

Huang D. W., Sherman B. T., Lempicki R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols. 2009;4(1):44–57. doi: 10.1038/nprot.2008.211. PubMed DOI

Liberzon A., Subramanian A., Pinchback R., Thorvaldsdóttir H., Tamayo P., Mesirov J. P. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739–1740. doi: 10.1093/bioinformatics/btr260. PubMed DOI PMC

Subramanian A., Tamayo P., Mootha V. K., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Acadamy of Sciences of the United States of America. 2005;102(43):15545–15550. doi: 10.1073/pnas.0506580102. PubMed DOI PMC

Project R. https://www.r-project.org.

Rennoll S. A., Konsavage W. M., Yochum G. S. Nuclear AXIN2 represses MYC gene expression. Biochemical and Biophysical Research Communications. 2014;443(1):217–222. doi: 10.1016/j.bbrc.2013.11.089. PubMed DOI PMC

Chen L., Pan X., Hu X., et al. Gene expression differences among different MSI statuses in colorectal cancer. International Journal of Cancer. 2018;143(7):1731–1740. doi: 10.1002/ijc.31554. PubMed DOI

D'Errico M., de Rinaldis E., Blasi M. F., et al. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. European Journal of Cancer. 2009;45(3):461–469. doi: 10.1016/j.ejca.2008.10.032. PubMed DOI

Budinska E., Popovici V., Tejpar S., et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. The Journal of Pathology. 2013;231(1):63–76. doi: 10.1002/path.4212. PubMed DOI PMC

Using empirical biological knowledge to infer regulatory networks from multi-omics data